What does this video actually claim?
Karla Colin (@karlaacolin) posted a 49.5K-view TikTok expressing being "SHOOK" about something related to GLP-1 medications like Ozempic or Mounjaro. Without seeing the specific content, her reaction suggests surprise about these weight management drugs.
The caption gives us little to work with beyond her emotional response. This type of vague content often spreads incomplete information about semaglutide and tirzepatide, two medications that have generated significant social media buzz.
What do we actually know about GLP-1 drugs?
The science on these medications isn't shocking - it's been building for years. Semaglutide (Ozempic/Wegovy) works by mimicking GLP-1 hormones that slow gastric emptying and reduce appetite.
The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% weight loss at 68 weeks with 2.4mg semaglutide versus 2.4% with placebo. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed tirzepatide achieving up to 22.5% weight reduction with the 15mg dose.
These results were significant but not mysterious. The drugs target well-understood biological pathways.
Why are people "shook" by these medications?
Social media amplifies both success stories and side effects, creating an all-or-nothing narrative. Users often don't realize these medications underwent rigorous clinical testing involving thousands of participants.
The STEP program included over 4,500 people across multiple trials. The SURMOUNT studies enrolled more than 2,500 participants each. This isn't some underground weight loss secret.
What genuinely surprises researchers is the medications' effects beyond weight loss. The SELECT trial (Ryan et al., NEJM, 2023) found semaglutide reduced major cardiovascular events by 20% in people without diabetes.
What's actually worth knowing about side effects?
The real story isn't shocking - it's about managing expectations. In STEP 1, 74% of semaglutide users experienced gastrointestinal side effects versus 48% on placebo.
Most people get nausea, vomiting, or diarrhea during dose escalation. These effects typically improve after 4-8 weeks. Starting at 0.25mg weekly and increasing gradually helps minimize problems.
Serious side effects exist but aren't common. Pancreatitis occurred in 0.2% of users in clinical trials. Gallbladder problems affected about 1.5% of participants. These aren't earth-shattering numbers.
What should you actually expect?
Skip the shock and focus on realistic outcomes. Most people lose 10-15% of body weight if they stick with treatment for a year. That's meaningful but not magical.
The medications cost $900-1,300 monthly without insurance coverage. Many people regain weight if they stop treatment, which the STEP 1 extension study clearly demonstrated.
You'll need regular medical monitoring for side effects and dose adjustments. The process takes patience, not just a prescription.